SENATE

Ren in Pharmaceutical Companies
June 26, 2019

The Connection between the FDA, Pharmaceutical Companies, and Addiction

One of the most common questions I hear regarding addiction is, “How did the addiction epidemic get so bad?” And I can see why people ask this.

read more...

Ren in Opioids
June 7, 2019

Treating Pain While Avoiding Addiction—How Can We Help Pain Patients and Also Reduce Opioid Consumption?

An article in the Washington Post from early April 2019 focuses on Kirsten Gillibrand, a Senator from New York and a possible contender for the presidential candidacy in 2020. The article discusses Gillibrand’s efforts to curb the opioid crisis and the criticism she has received in doing so.

read more...

Ren in U.S. Government
November 15, 2018

A Bipartisan Senate and House Agreed on a New Health Accord: What This Means for the Addiction Epidemic

One of the big news items to hit the airwaves recently was Congress’s new health agreement. This was a bipartisan event in which both Democrats and Republicans from the Senate and the House of Representatives alike agreed on something. Amazing.

read more...

Karen in Opioid Crisis
July 14, 2018

Missouri’s Struggle with Opioid Painkillers Revealed in Senate Report

In July 2018, a U.S. Senate report revealed the massive overprescribing of opioid painkillers to Missourians that has been going on unabated for years.

read more...

Karen in Pharmaceutical Companies
December 20, 2017

Failed Senate Investigation Could Have Saved Lives

In 2012, the Senate Finance Committee opened an investigation that could have revealed a hidden influence contributing to the loss of thousands of American lives. IF the report on this investigation had ever been published.

read more...